Ortho's VITROS(R) SARS-CoV-2 Antigen Test for High-Volume COVID-19 Testing Receives CE Mark; Allows for More Convenient Sample Collection and Expanded Viral Transport Media

RARITAN, N.J., April 13, 2021 -- (Healthcare Sales & Marketing Network) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it received CE Marking for its VITROS® SARS-CoV-... Diagnostics, Regulatory Ortho Clinical Diagnostics, VITROS, SARS-CoV-2, Antigen Test
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news